secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001932393-24-000012
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare Q4 revenue $5.2B (+5% organic); Adj EPS $1.18; guides FY2024 Adj EPS $4.20-4.35
--------------------------------------------------------------------------------

- Q4 revenue $5.2B (+5% organic); net income $403M vs $554M; Adj EBIT margin 16.1% vs 17.1%.
- FY 2023 revenue $19.6B (+8% organic); net income $1.6B; Adj EPS $3.93 vs $4.63 prior year.
- Free cash flow Q4 $956M; repaid $850M debt in Q4 and $150M in Jan 2024.
- FY2024 guidance: organic rev ~4% growth, Adj EBIT margin 15.6-15.9%, Adj EPS $4.20-4.35, FCF ~$1.8B.
- Segment: Imaging +4% organic, Ultrasound -2%, Patient Care +4%, Pharma Diagnostics +23%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000012/0001932393-24-000012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000012/gehc-20240206.htm
  HTML page:      https://secwatch.observer/filing/0001932393-24-000012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer